431 related articles for article (PubMed ID: 16682950)
1. Involvement of programmed cell death 4 in transforming growth factor-beta1-induced apoptosis in human hepatocellular carcinoma.
Zhang H; Ozaki I; Mizuta T; Hamajima H; Yasutake T; Eguchi Y; Ideguchi H; Yamamoto K; Matsuhashi S
Oncogene; 2006 Oct; 25(45):6101-12. PubMed ID: 16682950
[TBL] [Abstract][Full Text] [Related]
2. Lentiviral-mediated Smad4 RNAi induced anti-proliferation by p16 up-regulation and apoptosis by caspase 3 down-regulation in hepatoma SMMC-7721 cells.
Huang S; Zhang F; Miao L; Zhang H; Fan Z; Wang X; Ji G
Oncol Rep; 2008 Nov; 20(5):1053-9. PubMed ID: 18949401
[TBL] [Abstract][Full Text] [Related]
3. Activation of caspase-8 in transforming growth factor-beta-induced apoptosis of human hepatoma cells.
Shima Y; Nakao K; Nakashima T; Kawakami A; Nakata K; Hamasaki K; Kato Y; Eguchi K; Ishii N
Hepatology; 1999 Nov; 30(5):1215-22. PubMed ID: 10534343
[TBL] [Abstract][Full Text] [Related]
4. ICE-like protease (caspase) is involved in transforming growth factor beta1-mediated apoptosis in FaO rat hepatoma cell line.
Choi KS; Lim IK; Brady JN; Kim SJ
Hepatology; 1998 Feb; 27(2):415-21. PubMed ID: 9462639
[TBL] [Abstract][Full Text] [Related]
5. Insulin receptor substrate 1 overexpression in human hepatocellular carcinoma cells prevents transforming growth factor beta1-induced apoptosis.
Tanaka S; Wands JR
Cancer Res; 1996 Aug; 56(15):3391-4. PubMed ID: 8758899
[TBL] [Abstract][Full Text] [Related]
6. Attenuation of transforming growth factor beta-induced growth inhibition in human hepatocellular carcinoma cell lines by cyclin D1 overexpression.
Jong HS; Lee HS; Kim TY; Im YH; Park JW; Kim NK; Bang YJ
Biochem Biophys Res Commun; 2002 Mar; 292(2):383-9. PubMed ID: 11906173
[TBL] [Abstract][Full Text] [Related]
7. Inhibition mechanism of a newly cloned candidate tumor suppressor gene JST during hepatocarcinogenesis and its abnormal expression in human hepatocellular carcinoma from Qidong liver cancer risk area, China.
Dong-Dong L; Xi-Ran Z
Hepatogastroenterology; 2004; 51(56):515-25. PubMed ID: 15086194
[TBL] [Abstract][Full Text] [Related]
8. Smad protein mediated transforming growth factor beta1 induction of apoptosis in the MDPC-23 odontoblast-like cell line.
He WX; Niu ZY; Zhao SL; Smith AJ
Arch Oral Biol; 2005 Nov; 50(11):929-36. PubMed ID: 16183370
[TBL] [Abstract][Full Text] [Related]
9. Expression of transforming growth factor-beta 1 in hepatocellular carcinoma in comparison with the non-tumor tissue.
Idobe Y; Murawaki Y; Kitamura Y; Kawasaki H
Hepatogastroenterology; 2003; 50(49):54-9. PubMed ID: 12629989
[TBL] [Abstract][Full Text] [Related]
10. The gene expression level of transforming growth factor-beta (TGF-beta) as a biological prognostic marker of hepatocellular carcinoma.
Ikeguchi M; Iwamoto A; Taniguchi K; Katano K; Hirooka Y
J Exp Clin Cancer Res; 2005 Sep; 24(3):415-21. PubMed ID: 16270528
[TBL] [Abstract][Full Text] [Related]
11. Induction of PDCD4 tumor suppressor gene expression by RAR agonists, antiestrogen and HER-2/neu antagonist in breast cancer cells. Evidence for a role in apoptosis.
Afonja O; Juste D; Das S; Matsuhashi S; Samuels HH
Oncogene; 2004 Oct; 23(49):8135-45. PubMed ID: 15361828
[TBL] [Abstract][Full Text] [Related]
12. TGF-beta1-promoted epithelial-to-mesenchymal transformation and cell adhesion contribute to TGF-beta1-enhanced cell migration in SMMC-7721 cells.
Xu Z; Shen MX; Ma DZ; Wang LY; Zha XL
Cell Res; 2003 Oct; 13(5):343-50. PubMed ID: 14672557
[TBL] [Abstract][Full Text] [Related]
13. Expression of Smad7 in hepatocellular carcinoma and dysplastic nodules: resistance mechanism to transforming growth factor-beta.
Park YN; Chae KJ; Oh BK; Choi J; Choi KS; Park C
Hepatogastroenterology; 2004; 51(56):396-400. PubMed ID: 15086168
[TBL] [Abstract][Full Text] [Related]
14. Involvement of interferon regulatory factor 1 and S100C/A11 in growth inhibition by transforming growth factor beta 1 in human hepatocellular carcinoma cells.
Miyazaki M; Sakaguchi M; Akiyama I; Sakaguchi Y; Nagamori S; Huh NH
Cancer Res; 2004 Jun; 64(12):4155-61. PubMed ID: 15205326
[TBL] [Abstract][Full Text] [Related]
15. TGF-beta1-induced cell growth arrest and partial differentiation is related to the suppression of Id1 in human hepatoma cells.
Damdinsuren B; Nagano H; Kondo M; Natsag J; Hanada H; Nakamura M; Wada H; Kato H; Marubashi S; Miyamoto A; Takeda Y; Umeshita K; Dono K; Monden M
Oncol Rep; 2006 Feb; 15(2):401-8. PubMed ID: 16391861
[TBL] [Abstract][Full Text] [Related]
16. Clinical impact of plasma TGF-beta1 and circulating TGF-beta1 mRNA in diagnosis of hepatocellular carcinoma.
Dong ZZ; Yao DF; Yao M; Qiu LW; Zong L; Wu W; Wu XH; Yao DB; Meng XY
Hepatobiliary Pancreat Dis Int; 2008 Jun; 7(3):288-95. PubMed ID: 18522884
[TBL] [Abstract][Full Text] [Related]
17. Modulation of nuclear steroid receptors by ursodeoxycholic acid inhibits TGF-beta1-induced E2F-1/p53-mediated apoptosis of rat hepatocytes.
Solá S; Castro RE; Kren BT; Steer CJ; Rodrigues CM
Biochemistry; 2004 Jul; 43(26):8429-38. PubMed ID: 15222754
[TBL] [Abstract][Full Text] [Related]
18. Overexpression of regucalcin suppresses cell response for tumor necrosis factor-alpha or transforming growth factor-beta1 in cloned normal rat kidney proximal tubular epithelial NRK52E cells.
Nakagawa T; Yamaguchi M
J Cell Biochem; 2007 Apr; 100(5):1178-90. PubMed ID: 17063480
[TBL] [Abstract][Full Text] [Related]
19. p53 dephosphorylation and p21(Cip1/Waf1) translocation correlate with caspase-3 activation in TGF-beta1-induced apoptosis of HuH-7 cells.
Fan G; Ma X; Wong PY; Rodrigues CM; Steer CJ
Apoptosis; 2004 Mar; 9(2):211-21. PubMed ID: 15004518
[TBL] [Abstract][Full Text] [Related]
20. Expression of transforming growth factors in hepatocellular carcinoma and its relations with clinicopathological parameters and prognosis.
Lu Y; Wu LQ; Li CS; Wang SG; Han B
Hepatobiliary Pancreat Dis Int; 2008 Apr; 7(2):174-8. PubMed ID: 18397854
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
